Digital Technology to Deliver a Lifestyle-Integrated Exercise Intervention in Young Seniors-The PreventIT Feasibility Randomized Controlled Trial

Kristin Taraldsen, A Stefanie Mikolaizak, Andrea B Maier, Sabato Mellone, Elisabeth Boulton, Kamiar Aminian, Clemens Becker, Lorenzo Chiari, Turid Follestad, Brenda Gannon, Aniosora Paraschiv-Ionescu, Mirjam Pijnappels, Ingvild Saltvedt, Michael Schwenk, Chris Todd, Fan B Yang, Anna Zacchi, Jeanine van Ancum, Beatrix Vereijken, Jorunn L Helbostad, Kristin Taraldsen, A Stefanie Mikolaizak, Andrea B Maier, Sabato Mellone, Elisabeth Boulton, Kamiar Aminian, Clemens Becker, Lorenzo Chiari, Turid Follestad, Brenda Gannon, Aniosora Paraschiv-Ionescu, Mirjam Pijnappels, Ingvild Saltvedt, Michael Schwenk, Chris Todd, Fan B Yang, Anna Zacchi, Jeanine van Ancum, Beatrix Vereijken, Jorunn L Helbostad

Abstract

Background: Behavioral change is the key to alter individuals' lifestyle from sedentary to active. The aim was to assess the feasibility of delivering a Lifestyle-integrated Functional Exercise programme and evaluate the delivery of the intervention by use of digital technology (eLiFE) to prevent functional decline in 61-70 year-old adults. Methods: This multicentre, feasibility randomized controlled trial was run in three countries (Norway, Germany, and the Netherlands). Out of 7,500 potential participants, 926 seniors (12%) were screened and 180 participants randomized to eLiFE (n = 61), aLiFE (n = 59), and control group (n = 60). eLiFE participants used an application on smartphones and smartwatches while aLiFE participants used traditional paper-based versions of the same lifestyle-integrated exercise intervention. Participants were followed for 12 months, with assessments at baseline, after a 6 month active trainer-supported intervention, and after a further 6 months of unsupervised continuation of the programme. Results: At 6 months, 87% of participants completed post-test, and 77% completed the final assessment at 12 months. Participants were willing to be part of the programme, with compliance and reported adherence relatively high. Despite small errors during start-up in the technological component, intervention delivery by use of technology appeared acceptable. No serious adverse events were related to the interventions. All groups improved regarding clinical outcomes over time, and complexity metrics show potential as outcome measure in young seniors. Conclusion: This feasibility RCT provides evidence that an ICT-based lifestyle-integrated exercise intervention, focusing on behavioral change, is feasible and safe for young seniors. Clinical Trial Registration: ClinicalTrials.gov, identifier: NCT03065088. Registered on 14 February 2017.

Keywords: balance; behavioral change; mHealth; muscle strength; physical activity.

Copyright © 2020 Taraldsen, Mikolaizak, Maier, Mellone, Boulton, Aminian, Becker, Chiari, Follestad, Gannon, Paraschiv-Ionescu, Pijnappels, Saltvedt, Schwenk, Todd, Yang, Zacchi, van Ancum, Vereijken and Helbostad.

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
eLiFE participants' interactions with the app.

References

    1. Collaborators GBDM. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the global burden of disease study 2016. Lancet. (2017) 390:1084–150. 10.1016/S0140-6736(17)31833-0
    1. Salive ME. Multimorbidity in older adults. Epidemiol Rev. (2013) 35:75–83. 10.1093/epirev/mxs009
    1. Chatterji S, Byles J, Cutler D, Seeman T, Verdes E. Health, functioning, and disability in older adults–present status and future implications. Lancet. (2015) 385:563–75. 10.1016/S0140-6736(14)61462-8
    1. Organization WH . Strategy and Action Plan for Healthy Ageing in Europe, 2012-2020 (2012).
    1. French DP, Olander EK, Chisholm A, Mc Sharry J. Which behaviour change techniques are most effective at increasing older adults' self-efficacy and physical activity behaviour? a systematic review. Behav Med. (2014) 48:225–34. 10.1007/s12160-014-9593-z
    1. Murray JM, Brennan SF, French DP, Patterson CC, Kee F, Hunter RF. Effectiveness of physical activity interventions in achieving behaviour change maintenance in young and middle aged adults: a systematic review and meta-analysis. Soc Sci Med. (2017) 192:125–33. 10.1016/j.socscimed.2017.09.021
    1. Clemson L, Fiatarone Singh MA, Bundy A, Cumming RG, Manollaras K, O'Loughlin P, et al. . Integration of balance and strength training into daily life activity to reduce rate of falls in older people (the LiFE study): randomised parallel trial. (2012) 345:e4547. 10.1136/bmj.e4547
    1. Helbostad JL, Vereijken B, Becker C, Todd C, Taraldsen K, Pijnappels M, et al. . Mobile health applications to promote active and healthy ageing. Sensors. (2017) 17:622. 10.3390/s17030622
    1. Jonkman NH, van Schooten KS, Maier AB, Pijnappels M. eHealth interventions to promote objectively measured physical activity in community-dwelling older people. Maturitas. (2018) 113:32–9. 10.1016/j.maturitas.2018.04.010
    1. Muellmann S, Forberger S, Mollers T, Broring E, Zeeb H, Pischke CR. Effectiveness of eHealth interventions for the promotion of physical activity in older adults: a systematic review. Prev Med. (2018) 108:93–110. 10.1016/j.ypmed.2017.12.026
    1. Mercer K, Li M, Giangregorio L, Burns C, Grindrod K. Behavior change techniques present in wearable activity trackers: a critical analysis. JMIR Mhealth Uhealth. (2016) 4:e40. 10.2196/mhealth.4461
    1. Patel MS, Asch DA, Volpp KG. Wearable devices as facilitators, not drivers, of health behavior change. JAMA. (2015) 313:459–60. 10.1001/jama.2014.14781
    1. Taraldsen K, Mikolaizak AS, Maier AB, Boulton E, Aminian K, van Ancum J, et al. . Protocol for the prevent IT feasibility randomised controlled trial of a lifestyle-integrated exercise intervention in young older adults. BMJ Open. (2019) 9:e023526. 10.1136/bmjopen-2018-023526
    1. Jonkman NH, Del Panta V, Hoekstra T, Colpo M, van Schoor NM, Bandinelli S, et al. . Predicting trajectories of functional decline in 60- to 70-year-old people. Gerontology. (2018) 64:212–21. 10.1159/000485135
    1. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. (2005) 53:695–9. 10.1111/j.1532-5415.2005.53221.x
    1. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. App Psychol Measure. (1977) 1:385–401. 10.1177/014662167700100306
    1. Schwenk M, Bergquist R, Boulton E, Van Ancum JM, Nerz C, Weber M, et al. . The adapted lifestyle-integrated functional exercise program for preventing functional decline in young seniors: development and initial evaluation. Gerontology. (2019) 65:362–74. 10.1159/000499962
    1. Boulton E, Hawley-Hague H, French DP, Mellone S, Zacchi A, Clemson L, et al. . Implementing behaviour change theory and techniques to increase physical activity and prevent functional decline among adults aged 61-70: the preventIT project. Prog Cardiovasc Dis. (2019) 62:147–56. 10.1016/j.pcad.2019.01.003
    1. Organization WH . Global Recommendations on Physical Activity for Health (2010).
    1. Newman-Beinart NA, Norton S, Dowling D, Gavriloff D, Vari C, Weinman JA, et al. . The development and initial psychometric evaluation of a measure assessing adherence to prescribed exercise: the Exercise Adherence Rating Scale (EARS). Physiotherapy. (2017) 103:180–5. 10.1016/j.physio.2016.11.001
    1. Gardner B, Abraham C, Lally P, de Bruijn GJ. Towards parsimony in habit measurement: testing the convergent and predictive validity of an automaticity subscale of the self-report habit index. Int J Behav Nutr Phys Act. (2012) 9:102. 10.1186/1479-5868-9-102
    1. Brooke J. SUS—a quick and dirty usability scale. Usabil. Evaluation Industry. (1996) 189:4–7.
    1. Ware J, Kosinski M, Keller SD. A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. (1996) 34:220–33. 10.1097/00005650-199603000-00003
    1. Chiari L, Becker C, Pfeiffer K, Lindemann UWZ. Classification of the User's Needs, Characteristics and Scenarios—Update. Deliverable 2.2 (2009).
    1. Haley SM, Jette AM, Coster WJ, Kooyoomjian JT, Levenson S, Heeren T, et al. . Late life function and disability instrument: II. development and evaluation of the function component. J Gerontol A Biol Sci Med Sci. (2002) 57:M217–22. 10.1093/gerona/57.4.M217
    1. Jette AM, Haley SM, Coster WJ, Kooyoomjian JT, Levenson S, Heeren T, et al. . Late life function and disability instrument: I. development and evaluation of the disability component. J Gerontol A Biol Sci Med Sci. (2002) 57:M209–16. 10.1093/gerona/57.4.M209
    1. Paraschiv-Ionescu A, Büla CJ, Major K, Lenoble-Hoskovec C, Krief H, El-Moufawad C, et al. . Concern about falling and complexity of free-living physical activity patterns in well-functioning older adults. Gerontology. (2018) 64:1–9. 10.1159/000490310
    1. Fadlallah B, Chen B, Keil A, Principe J. Weighted-permutation entropy: a complexity measure for time series incorporating amplitude information. Phys Rev E Stat Nonlin Soft Matter Phys. (2013) 87:022911. 10.1103/PhysRevE.87.022911
    1. Group E. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. (1990) 16:199–208. 10.1016/0168-8510(90)90421-9
    1. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. (2017) 27:7–22. 10.1002/hec.3564
    1. Ludwig K, Graf von der Schulenburg JM, Greiner W. German value set for the EQ-5D-5L. Pharmacoeconomics. (2018) 36:663–74. 10.1007/s40273-018-0615-8
    1. Versteegh MM, Vermeulen MK, Evers MAAS, de Wit GA, Prenger R, Stolk AE. Dutch tariff for the five-level version of EQ-5D. Value Health. (2016) 19:343–52. 10.1016/j.jval.2016.01.003
    1. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. (1990) 300:230–5. 10.1136/bmj.300.6719.230
    1. Gomes M, Ng ES, Grieve R, Nixon R, Carpenter J, Thompson SG. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Making. (2012) 32:350–61. 10.1177/0272989X11418372
    1. van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. (1994) 3:309–19. 10.1002/hec.4730030505
    1. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ. (2004) 13:405–15. 10.1002/hec.903
    1. Lutomski JE, Krabbe PF, Bleijenberg N, Blom J, Kempen GI, MacNeil-Vroomen J, et al. . Measurement properties of the EQ-5D across four major geriatric conditions: findings from TOPICS-MDS. Health Qual Life Outcomes. (2017) 15:45. 10.1186/s12955-017-0616-x

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner